Related Experiment Video
Updated: Jul 18, 2026

Microglia as a Surrogate Biosensor to Determine Nanoparticle Neurotoxicity
Published on: October 25, 2016
Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to
Donald M Kuhn1, Dina M Francescutti-Verbeem, David M Thomas
1John D. Dingell VA Medical Center, Research & Development Service (11R), 4646 John R, Detroit, MI 48201, USA. donald.kuhn@wayne.edu
Abstract:
Methamphetamine (METH) intoxication leads to persistent damage of dopamine (DA) nerve endings of the striatum. Recently, we and others have suggested that the neurotoxicity associated with METH is mediated by extensive microglial activation. DA itself has been shown to play an obligatory role in METH neurotoxicity, possibly through the formation of quinone species. We show presently that DA-quinones (DAQ) cause a time-dependent activation of cultured microglial cells. Microarray analysis of the effects of DAQ on microglial gene expression revealed that 101 genes were significantly changed in expression, with 73 genes increasing and 28 genes decreasing in expression. Among those genes differentially regulated by DAQ were those often associated with neurotoxic conditions including inflammation, cytokines, chemokines, and prostaglandins. In addition, microglial genes associated with a neuronally protective phenotype were among those that were downregulated by DAQ. These results implicate DAQ as one species that could cause early activation of microglial cells in METH intoxication, manifested as an alteration in the expression of a broad biomarker panel of genes. These results also link oxidative stress, chemical alterations in DA to its quinone, and microglial activation as part of a cascade of glial-neuronal crosstalk that can amplify METH-induced neurotoxicity.
Insights
Methamphetamine neurotoxicity involves dopamine-quinone species activating microglia. This activation alters gene expression, potentially amplifying damage to dopamine nerve endings in the brain.
Area of Science:
- Neuroscience
- Toxicology
- Neuroinflammation
Background:
- Methamphetamine (METH) intoxication causes persistent damage to dopamine (DA) nerve endings.
- Microglial activation is implicated in METH-induced neurotoxicity.
- Dopamine (DA) plays a role in METH neurotoxicity, possibly via quinone formation.
Purpose of the Study:
- To investigate the role of dopamine-quinones (DAQ) in microglial activation.
- To analyze the impact of DAQ on microglial gene expression.
Main Methods:
- Cultured microglial cells were treated with DAQ.
- Microarray analysis was used to assess changes in microglial gene expression.
Main Results:
- DAQ induced time-dependent activation of microglial cells.
- 101 genes were significantly altered in expression by DAQ (73 increased, 28 decreased).
- Upregulated genes included those related to inflammation; downregulated genes included those associated with neuronal protection.
Conclusions:
- DAQ contributes to early microglial activation in METH intoxication.
- DAQ alters the expression of a broad panel of genes in microglia.
- This study links oxidative stress, DA conversion to DAQ, and microglial activation in a cascade amplifying METH neurotoxicity.
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Neurochemical Transmission: Sites of Drug Action
Drug Toxicity: Dose-Dependent Reactions
Parkinson Disease ll: Pathophysiology

